SPIA
SPRO icon

Steward Partners Investment Advisory’s Spero Therapeutics SPRO Stock Holding History

Steward Partners Investment Advisory’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$18K – 3312
2021
Q3 		$18K Hold
1,000
– – ﹤0.01% 2374
2021
Q2 		$14K Sell
1,000
-1,200
-55% -$16.8K ﹤0.01% 5618
2021
Q1 		$32.4K Buy
2,200
+300
+16% +$5.28K ﹤0.01% 2225
2020
Q4 		$37K Sell
1,900
-1,500
-44% -$23.4K ﹤0.01% 1816
2020
Q3 		$38K Sell
3,400
-2,800
-45% -$33.1K ﹤0.01% 1625
2020
Q2 		$84K Buy
+6,200
New +$69.6K ﹤0.01% 1221

Other funds holding SPRO

ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Steward Partners Investment Advisory's SPRO Position: Q4 2021 in Review

Steward Partners Investment Advisory sold out of Spero Therapeutics (SPRO) in Q4 2021, closing a stake of 1,000 shares — an estimated $18K sold.

Steward Partners Investment Advisory first reported a position in SPRO in Q2 2020 and held it in 6 quarters. The position peaked at $84K in Q2 2020. 84 funds tracked by Wall St. Rank hold SPRO as of Q4 2021.

  • Steward Partners Investment Advisory reported no remaining Spero Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,000 Spero Therapeutics shares in Q4 2021, an estimated $18K.
  • Steward Partners Investment Advisory first reported a position in Spero Therapeutics in Q2 2020 and held it in 6 quarters.
  • Steward Partners Investment Advisory's Spero Therapeutics position peaked at $84K in Q2 2020.
  • 84 funds tracked by Wall St. Rank held Spero Therapeutics as of Q4 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2021, filed 8 Feb 2022.